Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119968) titled 'A Randomized Controlled Trial of a Glutamate-Lowering Diet to Enhance the Efficacy of BCG Instillation Therapy for Basal/Squamous Subtype Bladder Cancer' on March 6.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Yantai Yuhuangding Hospital
Condition:
bladder cancer
Intervention:
Intervention Group :Glutamate-Lowering Diet Guidance + Standard BCG Therapy
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-31
Target Sample Size: Intervention Group :50;Control group:50;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org....